Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 3
1(20.0%)
5Total
N/A(4)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07243262Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)

Role: collaborator

NCT06453512Not ApplicableRecruiting

A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema

Role: collaborator

NCT03231007Completed

Saving Babies' Lives Project Impact and Results Evaluation: a Mixed Methodology Study

Role: collaborator

NCT03000504Not ApplicableUnknown

Ballooned Intercostal Drain Trial

Role: collaborator

NCT01969734Not ApplicableCompleted

Endobronchial Valves in Moderate COPD

Role: lead

NCT01869504Not ApplicableCompleted

A Feasibility and Safety Study of the Use of a Dedicated Ballooned Intercostal Drain

Role: lead

NCT00868062Phase 3Completed

Responses to Colloid Infusions

Role: collaborator

All 7 trials loaded